BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25389287)

  • 1. Knockout of nuclear high molecular weight FGF2 isoforms in mice modulates bone and phosphate homeostasis.
    Homer-Bouthiette C; Doetschman T; Xiao L; Hurley MM
    J Biol Chem; 2014 Dec; 289(52):36303-14. PubMed ID: 25389287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23 Neutralizing Antibody Partially Improves Bone Mineralization Defect of HMWFGF2 Isoforms in Transgenic Female Mice.
    Xiao L; Homer-Bouthiette C; Hurley MM
    J Bone Miner Res; 2018 Jul; 33(7):1347-1361. PubMed ID: 29502359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro.
    Xiao L; Esliger A; Hurley MM
    J Bone Miner Res; 2013 Jan; 28(1):35-45. PubMed ID: 22836867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice.
    Xiao L; Du E; Homer-Bouthiette C; Hurley MM
    Endocrinology; 2017 Oct; 158(10):3629-3646. PubMed ID: 28938491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
    Xiao L; Naganawa T; Lorenzo J; Carpenter TO; Coffin JD; Hurley MM
    J Biol Chem; 2010 Jan; 285(4):2834-46. PubMed ID: 19933269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice.
    Du E; Xiao L; Hurley MM
    J Cell Physiol; 2017 Mar; 232(3):610-616. PubMed ID: 27306296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of low-molecular-weight FGF2 isoform accelerates murine osteoarthritis while loss of high-molecular-weight FGF2 isoforms offers protection.
    Burt PM; Xiao L; Doetschman T; Hurley MM
    J Cell Physiol; 2019 Apr; 234(4):4418-4431. PubMed ID: 30144364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic mice.
    Sabbieti MG; Agas D; Marchetti L; Coffin JD; Xiao L; Hurley MM
    Endocrinology; 2013 Aug; 154(8):2723-33. PubMed ID: 23715864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF2 High Molecular Weight Isoforms Contribute to Osteoarthropathy in Male Mice.
    Meo Burt P; Xiao L; Dealy C; Fisher MC; Hurley MM
    Endocrinology; 2016 Dec; 157(12):4602-4614. PubMed ID: 27732085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.
    Montero A; Okada Y; Tomita M; Ito M; Tsurukami H; Nakamura T; Doetschman T; Coffin JD; Hurley MM
    J Clin Invest; 2000 Apr; 105(8):1085-93. PubMed ID: 10772653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice.
    Naganawa T; Xiao L; Coffin JD; Doetschman T; Sabbieti MG; Agas D; Hurley MM
    J Cell Biochem; 2008 Apr; 103(6):1975-88. PubMed ID: 17955502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.
    Liao S; Bodmer JR; Azhar M; Newman G; Coffin JD; Doetschman T; Schultz Jel J
    J Mol Cell Cardiol; 2010 Jun; 48(6):1245-54. PubMed ID: 20116383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity.
    He Q; Yang X; Gong Y; Kovalenko D; Canalis E; Rosen CJ; Friesel RE
    J Bone Miner Res; 2014; 29(5):1217-31. PubMed ID: 24127237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of FGFR Signaling Partially Rescues Osteoarthritis in Mice Overexpressing High Molecular Weight FGF2 Isoforms.
    Xiao L; Williams D; Hurley MM
    Endocrinology; 2020 Jan; 161(1):. PubMed ID: 31901095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway.
    Fei Y; Xiao L; Doetschman T; Coffin DJ; Hurley MM
    J Biol Chem; 2011 Nov; 286(47):40575-83. PubMed ID: 21987573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone.
    Sitara D; Kim S; Razzaque MS; Bergwitz C; Taguchi T; Schüler C; Erben RG; Lanske B
    PLoS Genet; 2008 Aug; 4(8):e1000154. PubMed ID: 18688277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF receptor inhibitor BGJ398 partially rescues osteoarthritis-like phenotype in older high molecular weight FGF2 transgenic mice via multiple mechanisms.
    Hurley MM; Coffin JD; Doetschman T; Valera C; Clarke K; Xiao L
    Sci Rep; 2022 Sep; 12(1):15968. PubMed ID: 36153352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells.
    Xiao L; Sobue T; Esliger A; Kronenberg MS; Coffin JD; Doetschman T; Hurley MM
    Bone; 2010 Aug; 47(2):360-70. PubMed ID: 20510392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF23 Regulates Wnt/β-Catenin Signaling-Mediated Osteoarthritis in Mice Overexpressing High-Molecular-Weight FGF2.
    Meo Burt P; Xiao L; Hurley MM
    Endocrinology; 2018 Jun; 159(6):2386-2396. PubMed ID: 29718273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
    Mahalingam CD; Datta T; Patil RV; Kreider J; Bonfil RD; Kirkwood KL; Goldstein SA; Abou-Samra AB; Datta NS
    J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.